Cefiderocol treatment of Pseudomonas aeruginosa and extensively drug-resistant Acinetobacter baumannii retained spinal hardware infection causing reversible acute interstitial nephritis

Critical analysis of antibacterial agents in clinical development

(2020) Ursula Theuretzbacher et al.   NATURE REVIEWS MICROBIOLOGY

Cefiderocol for extensively-drug resistant gram-negative bacterial infections: real-world experience from a case-series and review of the literature

(2020) Sandra Zingg et al.   Open Forum Infectious Diseases

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol

(2020) Michael Dagher et al.   Open Forum Infectious Diseases

Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient

(2020) Andrew B. Gainey et al.   PEDIATRIC PULMONOLOGY

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei

(2020) Soline Siméon et al.   Microorganisms

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report

(2019) Enrico Maria Trecarichi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Co-Infections of Two Strains of NDM-1 and OXA-232 Co-producing Klebsiella pneumoniae in a Kidney Transplant Patient

(2019) Deisy A. Contreras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long Term Compassionate Use of Cefiderocol to Treat Chronic Osteomyelitis Caused by XDR-Pseudomonas aeruginosa and ESBL-producing Klebsiella pneumoniae in a Pediatric Patient

(2019) Zain I. Alamarat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa

(2018) Jonathan D Edgeworth et al.   CLINICAL INFECTIOUS DISEASES